New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

2

U.S. CDC backs COVID-19 boosters for high-risk adults, workers, older Americans

The U.S. Centers for Disease Control and Prevention (CDC) on Sept. 24 backed a booster shot of the Pfizer and BioNTech Covid-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings.

6

WHO backs Regeneron COVID-19 drug cocktail as UN body calls for equal access

A World Health Organization (WHO) panel on Sept. 24 recommended the use of Regeneron and Roche’s Covid-19 antibody cocktail for patients at high risk of hospitalizations and those severely ill with no natural antibodies.

8

Q&A with CrowdPharm’s Mike Myers and Steve Bernstein

Med Ad News spoke with Mike Myers (managing director and partner of CrowdPharm and managing director and founder of Cross & Wild) and Steve Bernstein (CEO of Bernstein-Rein Advertising and CrowdPharm partner) about the combination of CrowdPharm and Cross & Wild, what makes CrowdPharm different from other agencies, and how they plan to expand the business in the future. 

9

Two FDA Wins in Two Days for Incyte

Incyte announced Sept. 22 that the Food and Drug Administration approved the company’s Jakafi (ruxolitinib) to treat chronic graft-versus-host disease, one day after the U.S. regulator gave the green light to the cream Opzelura (ruxolinitib) for the short-term and non-continuous chronic treatment of mild-to-moderate atopic dermatitis.